Endocrinology & Metabolic Research

Diabetes Mellitus Type 1

Type 1 Diabetes is a chronic autoimmune condition that affects millions worldwide, requiring lifelong insulin management and continuous monitoring. CenExel is committed to advancing innovative therapies and clinical research solutions to improve glucose control, reduce complications, and enhance quality of life for pediatric, adolescent, and adult patients living with Type 1 Diabetes.

Studies Conducted
0 +
Trial Participants
0 +
Active Centers
0
Overview

Advancing Type 1 Diabetes Clinical Research

CenExel provides specialized clinical research support for Type 1 Diabetes studies through experienced investigators, advanced metabolic monitoring, and patient-focused trial management. Our dedicated endocrinology teams work closely with sponsors to accelerate innovative diabetes therapies from early-phase development through post-market studies.

Conditions Covered

Diabetes Conditions We Research

Our Type 1 Diabetes research programs support a wide range of metabolic and endocrine-related conditions and treatment innovations.

  • Type 1 Diabetes Mellitus (T1D)
  • Pediatric Type 1 Diabetes
  • Insulin Resistance
  • Hypoglycemia Management
  • Continuous Glucose Monitoring (CGM)
  • Diabetic Ketoacidosis (DKA)
  • Autoimmune Endocrine Disorders
  • Insulin Pump Therapy
Our Approach

Why Sponsors Choose CenExel for Diabetes Research

CenExel combines scientific expertise, metabolic research capabilities, and patient-centered recruitment strategies to support successful diabetes clinical trials.

01

Endocrinology Specialists

Experienced diabetes investigators and certified endocrinology research teams across multiple research sites.

02

Advanced Glucose Monitoring

Access to CGM technologies, insulin pump integration, and real-time metabolic monitoring tools.

03

Diverse Patient Recruitment

Broad access to pediatric and adult Type 1 Diabetes patient populations across the United States.

04

High Retention Rates

Strong patient engagement programs designed to improve adherence and trial completion.

Phase Coverage

Supported Diabetes Trial Phases

CenExel supports early and late-phase diabetes research from first-in-human metabolic studies through Phase IV post-market trials.

Active across all phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Our diabetes research infrastructure supports insulin therapy evaluations, wearable glucose technologies, biomarker analysis, and precision metabolic medicine studies.

Let’s Advance Your Next Study

Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.

Explore Our Network

Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.

Our Blog